US 9096642
Therapeutic compounds for immunomodulation
granted A61KA61K38/00A61K38/08
Quick answer
US patent 9096642 (Therapeutic compounds for immunomodulation) held by Aurigene Discovery Technologies Limited expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61K38/08